GW Pharma Shares Clinical Trial Data to Support Epidiolex Safety and Efficacy

GW Pharma Shares Clinical Trial Data to Support Epidiolex Safety and Efficacy

Greenwich Biosciences, a GW Pharmaceuticals Company, Presents New Data for EPIDIOLEX® (cannabidiol) in Patients with Tuberous Sclerosis Complex (TSC) at the American Epilepsy Society Annual Meeting Study results showed EPIDIOLEX significantly reduced difficult-to-treat seizures associated with TSC and improved overall patient condition as reported by caregivers CARLSBAD, Calif., Dec. 07, 2019 (GLOBE NEWSWIRE) — GW […] READ MORE: https://www.newcannabisventures.com/gw-pharma-shares-clinical-trial-data-to-support-epidiolex-safety-and-efficacy/ The post GW Pharma Shares Clinical Trial Data to Support Epidiolex Safety and Efficacy appeared first on Cannabis Daily.

Excerpt only …
READ MORE BELOW
Source : New feed
Link to original : GW Pharma Shares Clinical Trial Data to Support Epidiolex Safety and Efficacy
reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.